Chao, Z.; Wang, Z.; Li, L.; Jiang, Y.; Tang, Y.; Wang, Y.; Hao, X.; Zhang, C.; Guo, X.; Yu, W.;
et al. Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials. Medicina 2023, 59, 2198.
https://doi.org/10.3390/medicina59122198
AMA Style
Chao Z, Wang Z, Li L, Jiang Y, Tang Y, Wang Y, Hao X, Zhang C, Guo X, Yu W,
et al. Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials. Medicina. 2023; 59(12):2198.
https://doi.org/10.3390/medicina59122198
Chicago/Turabian Style
Chao, Zheng, Zefeng Wang, Le Li, Yi Jiang, Yunxing Tang, Yanan Wang, Xiaodong Hao, Chunyu Zhang, Xiangdong Guo, Weimin Yu,
and et al. 2023. "Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials" Medicina 59, no. 12: 2198.
https://doi.org/10.3390/medicina59122198
APA Style
Chao, Z., Wang, Z., Li, L., Jiang, Y., Tang, Y., Wang, Y., Hao, X., Zhang, C., Guo, X., Yu, W., Cheng, F., & Wang, Z.
(2023). Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials. Medicina, 59(12), 2198.
https://doi.org/10.3390/medicina59122198